Access Packaging Safety Therapy 
The Cannigma
MAY 15, 2023
Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. 1 Related Stories What’s the deal with ketamine? 1 Related Stories What’s the deal with ketamine?
MMJ Recs
MARCH 20, 2024
Through these specialized services, Maryland dispensaries play a crucial role in providing accessible and quality medical cannabis options to patients statewide. These expansions aim to increase patient access and address supply shortages experienced in the past.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 31, 2022
Numinus Bioscience said that it is prepared to supply psilocybin in whole mushroom form, through three packaged doses equivalent to 10, 15, and 25mg of psilocybin. This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. Numinus Wellness Inc.
MMJ Recs
MARCH 2, 2024
In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. By utilizing the Ohio Medical Marijuana Dispensaries Map, patients can confidently explore their options and access quality medical cannabis products.
Cannabis Law Report
OCTOBER 29, 2019
ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.
Cannabis Law Report
JULY 1, 2021
In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.
The Joint Blog
AUGUST 8, 2023
Despite its legality, there are concerns about the safety and regulation of delta-8 THC products. Nevertheless, experts, including medical professionals and legislators, have raised concerns about the unregulated production and accessibility of delta-8 THC products. The safety of Delta-8 THC products is a subject of concern and debate.
Expert insights. Personalized for you.
78 
Let's personalize your content